Literature DB >> 14966909

Genomic instability of murine hepatocellular carcinomas with low and high metastatic capacities.

Shu-Hui Zhang1, Wen-Ming Cong, Jing-Quan Shi, Hong Wei.   

Abstract

AIM: To investigate the frequency of genomic instability in murine hepatocellular carcinoma (HCC) cell lines Hca/A2-P(P) and Hca/163-F(F) with low and high metastatic capacity, and to explore its association with the occurrence and metastasis of hepatocellular carcinomas.
METHODS: Forty microsatellite markers were randomly selected to examine P and F cells for genomic instability using PCR-simple sequence length polymorphism (PCR-SSLP) analysis.
RESULTS: Allelic genes on the chromosomes of P cell line with thirty informative microsatellite loci were paralleled to those of inbred strain C(3)H mouse, while those of F cell line with 28 loci were paralleled to those of inbred strain C(3)H mice. The frequency of microsatellite alterations was 37.5% and 42.5% in P cell line and F cell line, respectively. There were different alterations of allelic band 9 at loci between P and F cells, among which, the frequency of microsatellite alterations was most commonly seen on chromosomes 3, 7, 11 and 16.
CONCLUSION: Genomic instability in mouse chromosomes 3, 7, 11 and 16 may play a more important role in the development and progression of HCC in mice. It is suggested that these two sub-clones derived from a same hepatic tumor in homozygous mouse present different genetic features.

Entities:  

Mesh:

Year:  2004        PMID: 14966909      PMCID: PMC4716972          DOI: 10.3748/wjg.v10.i4.521

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Progress in research of liver surgery in China.

Authors:  Meng-Chao Wu; Feng Shen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 2.  Genetics of hepatocellular carcinoma.

Authors:  M A Buendia
Journal:  Semin Cancer Biol       Date:  2000-06       Impact factor: 15.707

3.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

4.  Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: comparison of loss of heterozygosity and replication error.

Authors:  H Kawai; T Suda; Y Aoyagi; O Isokawa; Y Mita; N Waguri; T Kuroiwa; M Igarashi; K Tsukada; S Mori; T Shimizu; Y Suzuki; Y Abe; T Takahashi; M Nomoto; H Asakura
Journal:  Hepatology       Date:  2000-06       Impact factor: 17.425

5.  Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan.

Authors:  Y H Chou; K C Chung; L B Jeng; T C Chen; Y F Liaw
Journal:  Cancer Lett       Date:  1998-01-16       Impact factor: 8.679

6.  Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.

Authors:  M Maggioni; G Coggi; B Cassani; P Bianchi; S Romagnoli; A Mandelli; M Borzio; P Colombo; M Roncalli
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

7.  Genomic aberrations in early stage human hepatocellular carcinomas.

Authors:  H Nagai; M Ponglikitmongkol; J Fujimoto; H Yamamoto; Y S Kim; N Konishi; K Matsubara
Journal:  Cancer       Date:  1998-02-01       Impact factor: 6.860

8.  Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

Authors:  N Rampino; H Yamamoto; Y Ionov; Y Li; H Sawai; J C Reed; M Perucho
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

9.  Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3' untranslated region mutations.

Authors:  E R Jupe; X T Liu; J L Kiehlbauch; J K McClung; R T Dell'Orco
Journal:  Cell Growth Differ       Date:  1996-07

Review 10.  Multiple mutations and cancer.

Authors:  Lawrence A Loeb; Keith R Loeb; Jon P Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.